Ibrexafungerp Citrate
Ibrexafungerp Citrate, an intravenous and orally bioavailable semisynthetic derivative of enfumafungin, is a triterpene antifungal agent indicated for the treatment of adult and postmenarchal pediatric females with vulvovaginal candidiasis (VVC). It is a glucan synthase inhibitor.
| Supplier | BOC Sciences |
|---|---|
| Product # | BBF-05812 |
| Pricing | Inquire |
| Cas | 1965291-08-0 |
| Molecular Weight | 922.17 |
| Molecular Formula | C50H75N5O11 |
| Canonical SMILES | CC(C)C(C)C1(CCC2(C3CCC4C5(COCC4(C3=CCC2(C1C(=O)O)C)CC(C5OCC(C)(C(C)(C)C)N)N6C(=NC=N6)C7=CC=NC=C7)C)C)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O |